Regeneron Pharmaceuticals
REGN
#288
Rank
โ‚ฌ65.72 B
Marketcap
620,16ย โ‚ฌ
Share price
-0.12%
Change (1 day)
-13.18%
Change (1 year)

Market capitalization of Regeneron Pharmaceuticals (REGN)

Market cap: โ‚ฌ65.72 Billion

As of December 2025 Regeneron Pharmaceuticals has a market cap of โ‚ฌ65.72 Billion. This makes Regeneron Pharmaceuticals the world's 288th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Regeneron Pharmaceuticals from 1996 to 2025

End of year Market Cap

Year Marketcap Change
2025โ‚ฌ65.72 B-12.63%
2024โ‚ฌ75.23 B-13.09%
2023โ‚ฌ86.55 B18.17%
2022โ‚ฌ73.24 B22.14%
2021โ‚ฌ59.96 B43.09%
2020โ‚ฌ41.91 B13.39%
2019โ‚ฌ36.96 B3.86%
2018โ‚ฌ35.58 B5.72%
2017โ‚ฌ33.66 B-8.54%
2016โ‚ฌ36.80 B-29.16%
2015โ‚ฌ51.95 B50.38%
2014โ‚ฌ34.55 B73.91%
2013โ‚ฌ19.86 B57.9%
2012โ‚ฌ12.58 B218.43%
2011โ‚ฌ3.95 B79.03%
2010โ‚ฌ2.20 B61.24%
2009โ‚ฌ1.36 B30.86%
2008โ‚ฌ1.04 B-19.8%
2007โ‚ฌ1.30 B31.11%
2006โ‚ฌ0.99 B31.32%
2005โ‚ฌ0.75 B99.74%
2004โ‚ฌ0.37 B-41.58%
2003โ‚ฌ0.64 B-17.62%
2002โ‚ฌ0.78 B-43.79%
2001โ‚ฌ1.40 B1.78%
2000โ‚ฌ1.37 B245.94%
1999โ‚ฌ0.39 B106.54%
1998โ‚ฌ0.19 B-13.61%
1997โ‚ฌ0.22 B-36.05%
1996โ‚ฌ0.34 B

End of Day market cap according to different sources

On Dec 4th, 2025 the market cap of Regeneron Pharmaceuticals was reported to be:

โ‚ฌ65.17 Billion
by Nasdaq info icon info icon
โ‚ฌ65.72 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Amgen
AMGN
โ‚ฌ157.15 B 139.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
โ‚ฌ52.74 B-19.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
โ‚ฌ22.90 B-65.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚ฌ418.56 B 536.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ218.02 B 231.70%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
โ‚ฌ102.41 B 55.81%๐Ÿ‡ซ๐Ÿ‡ท France